Severe liver disease reversed with semaglutide injections, study reveals
Scientist shares reversal of liver disease in new trial Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide was effective at treating fatty liver disease. Using semaglutide injections, scientists were able to reverse life-threatening cases … Read more